<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00604266</url>
  </required_header>
  <id_info>
    <org_study_id>07-0216</org_study_id>
    <nct_id>NCT00604266</nct_id>
  </id_info>
  <brief_title>Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study</brief_title>
  <acronym>PET/MRCP</acronym>
  <official_title>Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Toronto</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the feasibility and performance of coregistered 18F-FDG-PET/MRI in the staging of
      potentially respectable hilar cholangiocarcinoma.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Anticipated">August 2008</completion_date>
  <primary_completion_date type="Anticipated">August 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Cholangiocarcinoma</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>10-15 patients with potentially resectable hiilar cholangiocarcinoma</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Fifteen patients with potentially resectable hilar cholangiocarcinomas, as determined by
        conventional imaging modalities, will be recruited. In order to minimize false positive
        uptake of 18F-FDG due to inflammatory changes, patients will be recruited either before
        biliary stenting, or after biliary stenting if there is no clinical evidence of active
        cholangitis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hilar cholangiocarcinoma assessed by conventional imaging modalities (triphasic CT
             scan of the liver) and thought to be potentially resectable.

        Exclusion Criteria:

          -  Biliary drain inserted.

          -  Contraindication for MRI.

          -  Pregnant or breast-feeding.

          -  Uncontrolled diabetes (over 9.7 mmol/L).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ur Metser, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>U of Toronto, UHN</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UHN - Princess Margaret Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 17, 2008</study_first_submitted>
  <study_first_submitted_qc>January 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2008</study_first_posted>
  <last_update_submitted>May 1, 2017</last_update_submitted>
  <last_update_submitted_qc>May 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Toronto</investigator_affiliation>
    <investigator_full_name>Ur Metser</investigator_full_name>
    <investigator_title>Division Head, Molecular Imaging, Joint Department of Medical Imaging</investigator_title>
  </responsible_party>
  <keyword>Potentially resectable hilar cholangiocarcinoma as per initial imaging studies.</keyword>
  <keyword>Able to undergo PET/CT and MRI with Gadolinium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholangiocarcinoma</mesh_term>
    <mesh_term>Klatskin Tumor</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorodeoxyglucose F18</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

